Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Tracon Pharmaceuticals Inc (TCON)

Tracon Pharmaceuticals Inc (TCON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Tracon Pharmaceuticals Inc 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 USA

www.traconpharma.com Employees: 17 P: 858-550-0780

Description:

TRACON Pharmaceuticals, Inc. is a biopharmaceutical company. The company's product candidate includes TRC105, TRC205 and TRC102 which are in different clinical stage for cancer, age-related macular degeneration and fibrotic diseases. TRACON Pharmaceuticals, Inc. is headquartered in San Diego, California.

Key Statistics

Overview:

Market Capitalization, $K 110
Enterprise Value, $K -8,450
Shares Outstanding, K 3,408
Annual Sales, $ 12,050 K
Annual Net Income, $ -3,590 K
Last Quarter Sales, $ 60 K
Last Quarter Net Income, $ -2,840 K
EBIT, $ -7,300 K
EBITDA, $ 60 K
60-Month Beta 1.37
% of Insider Shareholders 5.27%
% of Institutional Shareholders 11.61%
Float, K 3,228
% Float 94.73%
Short Volume Ratio 0.44

Growth:

1-Year Return -99.20%
3-Year Return -99.94%
5-Year Return -99.94%
5-Year Revenue Growth 301.67%
5-Year Earnings Growth 99.15%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.94 on 08/13/24
Next Earnings Date 12/05/24
Earnings Per Share ttm 3.73
EPS Growth vs. Prev Qtr 29.32%
EPS Growth vs. Prev Year 21.67%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 04/10/24

TCON Ratios

Ratio
Price/Earnings ttm 0.01
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -237.65%
Return-on-Assets % 57.29%
Profit Margin % -29.79%
Debt/Equity 0.00
Price/Sales 0.01
Price/Cash Flow 0.02
Price/Book N/A
Book Value/Share -0.91
Interest Coverage -0.51
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar